We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Clinical Model Accurately Predicts Risk of Hip Fractures in Elderly

By HospiMedica International staff writers
Posted on 15 Oct 2024

Each year, thousands of hip fractures occur, causing significant pain for patients and increasing their dependence on family, friends, or healthcare staff. More...

Approximately 25% of those impacted die within the first year, resulting in a mortality rate that surpasses that of events such as strokes or heart attacks. This indicates that if clinicians can predict who is likely to be affected, they can implement preventive measures and potentially save lives. Currently, bone densitometry is the most widely utilized method for assessing fracture risk; however, it has several drawbacks. The examination is time-consuming, requires costly equipment, and is not readily accessible to all physicians. Researchers have now created a clinical model that can accurately predict the risk of hip fractures in older adults. This model can identify high-risk patients without the need for measuring skeletal strength, which can speed up the process for doctors and enable timely preventive treatment.

The new study conducted by researchers at Uppsala University (Uppsala, Sweden) is based on registry data gathered from the entire Swedish population. For five years, the researchers tracked all individuals living in Sweden aged 50 and older to identify factors that elevate the risk of hip fractures. The newly developed model relies on variables that are easier to collect in clinical environments, such as diagnoses and medical treatments. This enables healthcare personnel to perform risk assessments without needing access to bone densitometry equipment. The research model is founded on 19 variables, with the strongest predictors—apart from advanced age—being the use of home-help services and diagnoses such as Parkinson's disease and dementia. The model indicated that women utilizing home-help services face a nearly 8% risk of suffering a hip fracture within five years, while the corresponding risk for men is 5%.

A significant finding of the study was the establishment of a risk threshold for when treatment with bone-strengthening medications should be considered. If an individual has a 3% or higher risk of experiencing a hip fracture within five years, preventive medication could be advantageous. According to the model, 36 women or 52 men would therefore require treatment to avert a hip fracture. This study has also been validated among individuals from foreign backgrounds, demonstrating equal accuracy in that group. The research findings published in the journal eClinicalMedicine could inform new guidelines on how healthcare providers should approach the management of hip fracture risk in older adults.

“The most surprising result was that we could predict hip fractures so accurately without using bone density, which has traditionally been an important factor. This means that more people can be identified in time and offered preventive treatment,” said Peter Nordström, Professor and Consultant Physician who led the research group. “A major advantage of our model is that it is based on data already available in the clinic, which allows us to identify at-risk groups more quickly and easily. This in turn enables us to start preventive interventions earlier, such as medication for osteoporosis, and prevent serious complications that occur in hip fractures.”


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Endoscopy Display
E190
New
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The proposed hyperspectral endoscopic imaging system includes a spectral LED array in the catheter tip (Courtesy of N. Modir et al., doi 10.1117/1.JMI.12.3.035002)

LED-Based Imaging System Could Transform Cancer Detection in Endoscopy

Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.